Pharmacophore an International Research Journal
The problem of surgical treatment of cataracts in patients with concomitant glaucoma has been attracting the attention of ophthalmologists for many years. The work aimed to evaluate the effectiveness and safety of phacoemulsification with femtosupport in combination with glaucoma and cataract in combination with non-penetrating deep sclerectomy. The groups of patients differed according to the method of surgical intervention: phacoemulsification (271 eyes, 214 patients), phacoemulsification with femtosupport (461 eyes, 320 patients), phacoemulsification with non-penetrating deep sclerectomy with Xenoplast drainage implantation (14 eyes, 10 patients), phacoemulsification with non-penetrating deep sclerectomy with Xenoplast drainage implantation with femto-accompaniment (54 eyes, 43 patients). Visual acuity before surgery in the 1st group averaged 0.13, in the 2nd group 0.23, in the 3rd - 0.24, in the 4th - 0.14; 1 month after the operation 0.67, 0.72, 0.66, 0.68, respectively. In every instance, femtolaser support enabled the surgeon to speed up intraocular work. In none of the cases with a combination operation, there were any intraoperative hemorrhagic problems. It has been established that combined phacoemulsification and non-penetrating deep sclerectomy with Xenoplast implantation is an effective, safe intervention for the treatment of cataract and glaucoma patients on an outpatient basis. Femtosupport of phacoemulsification allows to reduce the time of intraocular work of the surgeon and does not lead to an increase in the number of surgical and postoperative complications.
